Eisai Expands Relationship With Johns Hopkins For Neurological Disorders, Partnering Through "Open Innovation"
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Eisai Co. Ltd. will build on its existing relationship with the Johns Hopkins Brain Science Institute, announcing a drug discovery collaboration for neurology Oct. 17